drugset / Trial / NCT07708493
A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight
NaSingle-groupOpen-labelTreatment
Summary
The main objectives of this trial are: To assess the mass balance (total recovery of \[14C\]-radioactivity) in urine, faeces, and expired air after a single subcutaneous dose of BI 3034701 (C-14) in healthy male trial participants.
Timeline
- Start
- 2026-07-29
- Primary completion
- 2026-10-14
- Completion
- 2026-10-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3034701 | Unknown | — | Subcutaneous |
Indications
No indication recorded.